A detailed history of Trail Ridge Investment Advisors, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Trail Ridge Investment Advisors, LLC holds 1,945 shares of UTHR stock, worth $604,972. This represents 0.26% of its overall portfolio holdings.

Number of Shares
1,945
Previous 1,635 18.96%
Holding current value
$604,972
Previous $359,000 24.23%
% of portfolio
0.26%
Previous 0.22%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$210.76 - $249.51 $65,335 - $77,348
310 Added 18.96%
1,945 $446,000
Q4 2023

Feb 16, 2024

BUY
$214.88 - $256.94 $23,636 - $28,263
110 Added 7.21%
1,635 $359,000
Q3 2023

Nov 14, 2023

BUY
$211.82 - $248.24 $9,108 - $10,674
43 Added 2.9%
1,525 $344,000
Q2 2023

Aug 14, 2023

BUY
$205.19 - $232.99 $74,278 - $84,342
362 Added 32.32%
1,482 $327,000
Q1 2023

May 12, 2023

BUY
$212.99 - $276.17 $238,548 - $309,310
1,120 New
1,120 $250,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $14.2B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Trail Ridge Investment Advisors, LLC Portfolio

Follow Trail Ridge Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trail Ridge Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trail Ridge Investment Advisors, LLC with notifications on news.